The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023
Drug Metabolism and Disposition · 2023
DOI: 10.1124/dmd.122.001012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Yurong Lai. Beteiligte Einrichtung: Drug Metabolism, Gilead Sciences Inc., Foster City, California yurong.lai@gilead.com. Hauptthemen laut MEDLINE: Coproporphyrins, Organic Anion Transporters. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drug Metabolism, Gilead Sciences Inc., Foster City, California yurong.lai@gilead.com.
ORCID-Profile: Yurong Lai
Zitieren
APA
Lai, Y. (2023). The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.122.001012
Vancouver
Lai Y. The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.122.001012
BibTeX
@article{Lai2023,
author = {Lai, Yurong},
title = {The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023},
journal = {Drug Metabolism and Disposition},
year = {2023},
doi = {10.1124/dmd.122.001012}
}
EUVIMED